NEW YORK (GenomeWeb News) – Vermillion reported after the close of the market on Tuesday that a drop in its product revenues led to a 28-percent decrease year over year in total revenues for the first quarter.

The company also announced that President and CEO Gail Page will be leaving the company by September and Vermillion has begun the process to find her successor.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.